Showing results for "Novartis"
markets
European Earnings Underway, iPhone Sales Plummet | Bloomberg Markets Today 04/23/2024European earnings season gets underway. Novartis raises its forecast as sales outperform. Renault also exceeds expectations. Apple's iPhone sales plummet in China and Euro private sector activity passes to the highest of the year. Markets Today has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Kriti Gupta and Guy Johnson. (Source: Bloomberg)April 23, 2024
markets
Novartis CEO: Broadly Positive About Business MomentumNovartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. “While there was a small contribution from generics getting pushed out, we’re reiterating our confidence in our 5% plus sales growth guidance up to 2028 and our 40% plus margin guidance out to 2027,” he told Bloomberg Television on Tuesday. Novartis raised its forecast as sales of blockbuster medicines for heart disease and psoriasis outpaceApril 23, 2024
industries
Zepbound, Ozempic for Weight Loss: Safety, Effectiveness and Shortages, ExplainedObesity is among the world’s most common health conditions, but for years medicine had few effective approaches to offer short of surgery. That’s why there’s been so much excitement about a new class of drugs that’s helping patients shed dozens of pounds at far lower risk — and generating billions in revenue for pharmaceutical companies.April 18, 2024